share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

Novavax | 4: Statement of changes in beneficial ownership of securities

诺瓦瓦克斯医药 | 4：持股变动声明
SEC announcement ·  03/12 20:49
Moomoo AI 已提取核心信息
John Trizzino, President and COO of Novavax Inc, completed a stock transaction on March 10, 2024. The transaction involved the sale of 2,226 shares of Novavax common stock at a price of $5.45 per share, resulting in a total market value of $12,131.70. Prior to this sale, Trizzino exercised options to acquire 4,608 shares of the company's stock. Following these transactions, Trizzino's direct holdings in Novavax amounted to 27,972 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
John Trizzino, President and COO of Novavax Inc, completed a stock transaction on March 10, 2024. The transaction involved the sale of 2,226 shares of Novavax common stock at a price of $5.45 per share, resulting in a total market value of $12,131.70. Prior to this sale, Trizzino exercised options to acquire 4,608 shares of the company's stock. Following these transactions, Trizzino's direct holdings in Novavax amounted to 27,972 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
Novavax Inc总裁兼首席运营官约翰·特里齐诺于2024年3月10日完成了股票交易。该交易涉及以每股5.45美元的价格出售2,226股Novavax普通股，总市值为12,131.70美元。在此次出售之前，Trizzino行使了期权收购了该公司4,608股股票。这些交易之后，Trizzino在Novavax的直接持股量为27,972股。此次出售是根据交易代码进行的，该交易代码表明通过交付或预扣证券来支付行使价或应纳税额。
Novavax Inc总裁兼首席运营官约翰·特里齐诺于2024年3月10日完成了股票交易。该交易涉及以每股5.45美元的价格出售2,226股Novavax普通股，总市值为12,131.70美元。在此次出售之前，Trizzino行使了期权收购了该公司4,608股股票。这些交易之后，Trizzino在Novavax的直接持股量为27,972股。此次出售是根据交易代码进行的，该交易代码表明通过交付或预扣证券来支付行使价或应纳税额。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息